Last reviewed · How we verify
Chloraprep
At a glance
| Generic name | Chloraprep |
|---|---|
| Also known as | 2% chlorhexidine gluconate / 70% Isopropyl alcohol, CHG 2% / IPA 70%, ChloraPrep Patient Preoperative Skin Preparation, ChloraPrep One-Step, Chlorhexidine gluconate 2% / Isopropyl alcohol 70% |
| Sponsor | Zurex Pharma, Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department (PHASE4)
- Aqueous vs Alcohol Chlorhexidine Skin Preparation for Prevention of Cesarean Section Wound Infections (PHASE4)
- Topical Antimicrobial Effectiveness Testing (PHASE4)
- Topical Antimicrobial Effectiveness Testing (PHASE4)
- Test for Pre Operative Skin Preparations (PHASE3)
- Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics (PHASE3)
- Preoperative Skin Preparation Evaluation (PHASE3)
- A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chloraprep CI brief — competitive landscape report
- Chloraprep updates RSS · CI watch RSS
- Zurex Pharma, Inc. portfolio CI